Gregory Moore
82Patents
13h-index
50Co-inventors
87Inventor score
Filing activity: Sep 21, 2002 → Feb 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8063187B2 | Methods and compositions for inhibiting CD32B expressing cells | Chemistry; Metallurgy | 109 | Active |
| US9856327B2 | Heterodimeric antibodies to CD3 X CD123 | Chemistry; Metallurgy | 64 | Active |
| US10227410B2 | Heterodimeric antibodies that bind CD3 and PSMA | Chemistry; Metallurgy | 29 | Active |
| US10428155B2 | Trispecific antibodies | Chemistry; Metallurgy | 28 | Active |
| US10526417B2 | Heterodimeric antibodies that bind CD3 and CD38 | Chemistry; Metallurgy | 25 | Active |
| US8362210B2 | Antibody variants with enhanced complement activity | Chemistry; Metallurgy | 25 | Active |
| US9493578B2 | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens | Chemistry; Metallurgy | 23 | Active |
| US9701759B2 | Heterodimeric proteins | Chemistry; Metallurgy | 23 | Active |
| US8314213B2 | Human equivalent monoclonal antibodies engineered from nonhuman variable regions | Chemistry; Metallurgy | 21 | Active |
| US9040041B2 | Modified FC molecules | Chemistry; Metallurgy | 18 | Active |
| US9605084B2 | Heterodimeric proteins | Chemistry; Metallurgy | 17 | Active |
| US9650446B2 | Heterodimeric proteins | Chemistry; Metallurgy | 17 | Active |
| US10793632B2 | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors | Chemistry; Metallurgy | 14 | Active |
| US10131710B2 | Optimized antibody variable regions | Chemistry; Metallurgy | 11 | Active |
| US9850320B2 | Heterodimeric antibodies to CD3 X CD20 | Chemistry; Metallurgy | 11 | Active |
| US10787518B2 | Bispecific checkpoint inhibitor antibodies | Chemistry; Metallurgy | 8 | Active |
| US9394366B2 | Methods and compositions for inhibiting CD32B expressing cells | Chemistry; Metallurgy | 8 | Active |
| US11225521B2 | Heterodimeric antibodies that bind somatostatin receptor 2 | Chemistry; Metallurgy | 8 | Active |
| US10316088B2 | Heterodimeric antibodies that bind somatostatin receptor 2 | Chemistry; Metallurgy | 8 | Active |
| US10259887B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 7 | Active |
| US9738722B2 | Rapid clearance of antigen complexes using novel antibodies | Chemistry; Metallurgy | 7 | Active |
| US11225528B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 7 | Active |
| US11591401B2 | Anti-CD28 compositions | Chemistry; Metallurgy | 7 | Active |
| US7610156B2 | Methods for rational pegylation of proteins | Physics | 7 | Expired |
| US9822186B2 | Bispecific antibodies that bind to CD38 and CD3 | Chemistry; Metallurgy | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.